EAPH Leadership has an excellent record and Creditability as documented below.
Information verified in the EAPH SEC June 2016 Filings listed below:
During the quarter ending June 30, 2015 Dr. Daniel Bagi, M.D. was appointed as COO
During the Quarter Ending June 30, 2015, the company appointed Mr. Nunzio Valerie as President / CFO / Director to the Company replacing John Adams who resigned as a director
During the Quarter Ending June 30, 2015, the company appointed Mr. Evan Karras as CEO / Treasurer / Director to the company in place of Carla Pepe who currently remains as Director / CFO.
During the 4th quarter of 2015, the Company appointed Dr. Jose Tiran Saucedo as Chief Medical Officer
During the Quarter Ending March 31, 2016, the Company accepted the resignation of Nunzio Valeri
??Q2 – June 30, 2016 Page 37
Easton Pharmaceuticals, Inc.
(A Development Stage Company)
Financial Statements For Quarter Ended June 30, 2016
Prepared By Management Without Audit ________________________________________________________________________________________
B. Legal/Disciplinary History. Please identify whether any of the foregoing persons have, in the last five years, been the subject of:
B1. A conviction in a criminal proceeding or named as a defendant in a pending criminal proceeding (excluding traffic violations and other minor offenses);
None
B2. The entry of an order, judgment, or decree, not subsequently reversed, suspended or vacated, by a court of competent jurisdiction that permanently or temporarily enjoined, barred, suspended or otherwise limited such person’s involvement in any type of business, securities, commodities, or banking activities;
None
B3. A finding or judgment by a court of competent jurisdiction (in a civil action), the Securities and Exchange Commission, the Commodity Futures Trading Commission, or a state securities regulator of a violation of federal or state securities or commodities law, which finding or judgment has not been reversed, suspended, or vacated; or
None
B4. The entry of an order by a self-regulatory organization that permanently or temporarily barred suspended or otherwise limited such person’s involvement in any type of business or securities activities.
None
